Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 19 filings · Latest: Aug 10, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Rodman David MalcomAug 13, 2026
Proposed Sale
$26.4814,056$372.2K
MLYS
David Malcom RodmanChief Medical OfficerAug 10, 2026
Sale
$27.092,170$58.8K51,384
MLYS
David Malcom RodmanChief Medical OfficerAug 10, 2026
Option Exercise
$16.002,170$34.7K53,554
MLYS
Rodman David MalcomAug 10, 2026
Proposed Sale
$27.092,170$58.8K
MLYS
David Malcom RodmanChief Medical OfficerJul 17, 2026
Sale
$26.53416$11.0K51,384
MLYS
David Malcom RodmanChief Medical OfficerJul 17, 2026
Option Exercise
$15.44416$6.4K51,800
MLYS
Rodman David MalcomJul 17, 2026
Proposed Sale
$26.48416$11.0K
MLYS
David Malcom RodmanChief Medical OfficerJul 15, 2026
Sale
$26.616,349$169.0K51,384
MLYS
David Malcom RodmanChief Medical OfficerJul 13, 2026
Sale
$27.5814,058$387.7K57,733
MLYS
David Malcom RodmanChief Medical OfficerJul 13, 2026
Option Exercise
$7.2814,058$102.4K71,791
MLYS
Rodman David MalcomJul 15, 2026
Proposed Sale
$26.616,349$169.0K
MLYS
Rodman David MalcomJul 13, 2026
Proposed Sale
$27.5814,058$387.7K
MLYS
Rodman David MalcomJul 13, 2026
Proposed Sale
$26.7214,508$387.7K
MLYS
David Malcom RodmanChief Medical OfficerJul 9, 2026
Sale
$30.302,171$65.8K57,733
MLYS
David Malcom RodmanChief Medical OfficerJul 9, 2026
Option Exercise
$16.002,171$34.7K59,904
MLYS
Rodman David MalcomJul 9, 2026
Proposed Sale
$30.302,171$65.8K
MLYS
David Malcom RodmanChief Medical OfficerJun 17, 2026
Sale
$25.004,584$114.6K57,095
MLYS
David Malcom RodmanChief Medical OfficerJun 17, 2026
Option Exercise
$14.364,584$65.8K61,679
MLYS
David Malcom RodmanChief Medical OfficerJun 15, 2026
Sale
$23.819,890$235.5K57,095
MLYS
David Malcom RodmanChief Medical OfficerJun 15, 2026
Option Exercise
$10.203,542$36.1K66,985

Page 1 of 5

Next →